Truist (TFC) Declares SCB, Rewards Shareholders With Buyback Plan

Per the Federal Reserve, following the clearance of the 2024 annual stress test, Truist Financial Corporation’s TFC preliminary stress capital buffer (SCB) requirement is 2.8%. This excludes the impact of the sale of Truist Insurance Holdings and the balance sheet repositioning that occurred on May 6.

While the company’s final SCB requirement will be determined on or before Aug 31, 2024, the new SCB requirement, once finalized, will be in effect from Oct 1, 2024, to Sep 30, 2025.

TFC’s board of directors has authorized a share repurchase program worth $5 billion through 2026, expected to begin in the third quarter of 2024.

Earlier, management had said that share repurchases were not a priority as the company was seeking to maintain higher capital levels. However, now, since the divestiture of the remaining stake in its insurance subsidiary is complete, TFC is in a position to resume buybacks.

Moreover, subject to approval from its board of directors, Truist plans to maintain its current quarterly common stock dividend of 52 cents per share.

While TFC hiked its quarterly dividend by 8.3% in 2022, the bank maintained the quarterly dividend at 52 cents, even after the clearance of the 2023 stress test.

Driven by a strong capital position and earnings strength, the company is expected to sustain enhanced capital distributions in the future.

Bill Rogers, the chairman and CEO of TFC stated, “Truist's 2024 annual stress test results again demonstrate the benefits of our diverse business mix and prudent and disciplined risk management culture. The net impact from the sale of TIH and the balance sheet repositioning, completed in May 2024, solidify Truist's strong liquidity and capital positions, increasing our first-quarter 2024 pro-forma CET1 ratio to 11.4%.”

Notably, the stress tests, mandated under the Dodd-Frank financial services law, were introduced in the aftermath of the 2008 financial crisis. They help evaluate banks' capital adequacy, liquidity and risk management practices under adverse hypothetical scenarios, such as a deep recession and/or a sharp decline in asset prices.

This time, all of Wall Street’s 31 banks cleared the Fed’s stress test. Thus, the banks are in a position to return excess capital to shareholders via dividends and share repurchases.

To name a few, JPMorgan JPM and Morgan Stanley MS are enhancing capital distribution plans post clearance of the test. JPM approved a new common share repurchase program totaling $30 billion, beginning Jul 1, 2024. MS has renewed a multi-year common equity share repurchase program of up to $20 billion, effective from the third quarter of 2024, with no specified expiration date.

At present, TFC carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

JPMorgan Chase & Co. (JPM) : Free Stock Analysis Report

Morgan Stanley (MS) : Free Stock Analysis Report

Truist Financial Corporation (TFC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.